PG
NYSE · USDOne year, rebased to 100
PG SPY XLP (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials · FY2026
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
PG vs industry median
112 companies in Household & Personal ProductsEarnings delivery
Next report 2026-10-22 · consensus EPS $1.88Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| PG The Procter & Gamble Company | $370.0B | 23.6x | 29.8% | 18.4% | +3.3% | +9.6% |
| CL Colgate-Palmolive Company | $75.0B | 37.0x | 434.3% | 12.9% | +5.2% | +21.3% |
| EL The Estée Lauder Companies | $37.9B | 205.0x | 4.7% | -3.2% | +5.1% | +8.4% |
| KO The Coca-Cola Company | $404.0B | 28.2x | 44.2% | 33.1% | +6.5% | +39.8% |
| PM Philip Morris International | $319.8B | 29.5x | -105.8% | 25.2% | +9.1% | +31.4% |
| COST Costco Wholesale Corporation | $438.3B | 47.6x | 28.4% | 3.1% | +10.1% | — |
| PEP PepsiCo, Inc. | $179.2B | 16.5x | 52.3% | 12.1% | +6.4% | — |
| BUD Anheuser-Busch InBev SA/NV | $163.3B | 14.0x | 18.6% | 19.8% | +2.9% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Narrow).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where PG sits among 20 scored companies in Household & Personal Products (0 = lowest value, 100 = highest). It is a position, not a grade.Valuation
| Measure | PG | Industry percentile |
|---|---|---|
| P/E (TTM) | 23.1x | 55th |
| PEG (P/E ÷ 3-yr EPS CAGR) | 5.99 | 100th |
| Price / sales | 4.3x | 100th |
| Price / book | 6.8x | 79th |
| Price / tangible book | — | |
| Price / free cash flow | 23.3x | 75th |
| Price / operating cash flow | 18.2x | 81st |
| Enterprise value | $395.1B | 100th |
| EV / sales | 4.5x | 100th |
| EV / EBITDA | 16.2x | 44th |
| EV / EBIT | 18.6x | 43rd |
| EV / free cash flow | 24.8x | 69th |
| Earnings yield | 4.3% | 68th |
| FCF yield | 4.3% | 37th |
| Operating cash flow yield | 5.5% | 32nd |
| Graham number (per share) | $57.80 | 91st |
Profitability (TTM)
| Measure | PG | Industry percentile |
|---|---|---|
| Gross margin | 50.2% | 53rd |
| EBITDA margin | 28.1% | 100th |
| Operating margin | 22.7% | 95th |
| EBIT margin | 24.4% | 100th |
| Net margin | 18.4% | 100th |
| NOPAT margin | 18.0% | 95th |
| FCF margin | 18.3% | 95th |
| Operating cash flow margin | 23.4% | 100th |
| R&D / revenue | 0.0% | 0th |
| SG&A / revenue | 27.5% | 26th |
| Stock comp / revenue | 0.6% | 33rd |
| Effective tax rate | 20.8% | 5th |
Returns on capital
| Measure | PG | Industry percentile |
|---|---|---|
| ROE (on average equity) | 30.2% | 84th |
| ROA | 12.7% | 100th |
| ROIC | 19.7% | 68th |
| ROCE | 24.2% | 95th |
| Return on tangible assets | 16.9% | 89th |
| Cash ROIC (OCF / invested capital) | 25.6% | 76th |
| Gross profitability (GP / assets) | 34.5% | 47th |
| ROIC, 3-yr average | 17.4% | 82nd |
| ROIC, 5-yr average | 20.6% | 93rd |
| ROE, 5-yr average | 30.6% | 88th |
| Incremental ROIC | 160.6% | 95th |
Growth
| Measure | PG | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | 3.3% | 68th |
| Revenue growth (QoQ) | -0.2% | 21st |
| Revenue CAGR, 3 yr | 2.0% | 56th |
| Revenue CAGR, 5 yr | 2.7% | 53rd |
| Gross profit CAGR, 3 yr | 3.6% | 39th |
| Operating income CAGR, 3 yr | 2.9% | 33rd |
| Net income growth (TTM YoY) | 0.5% | 50th |
| Net income CAGR, 3 yr | 3.1% | 30th |
| EPS growth (TTM YoY) | 1.8% | 50th |
| EPS CAGR, 3 yr | 3.8% | 30th |
| EPS CAGR, 5 yr | 3.6% | 78th |
| FCF growth (TTM YoY) | 13.3% | 15th |
| FCF CAGR, 3 yr | 4.9% | 46th |
| Operating cash flow CAGR, 3 yr | 6.4% | 57th |
| Book value CAGR, 3 yr | 5.9% | 65th |
| Dividend CAGR, 3 yr | 2.0% | 92nd |
| Sustainable growth rate | 10.9% | 73rd |
Margin history & stability
| Measure | PG | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | 50.9% | 53rd |
| Operating margin, 3-yr average | 23.0% | 100th |
| Net margin, 3-yr average | 18.4% | 100th |
| FCF margin, 3-yr average | 18.7% | 100th |
| Revenue stability (0-1) | 0.95 | 79th |
| Earnings stability (0-1) | 0.85 | 89th |
| Margin stability (0-1) | 0.97 | 74th |
Liquidity (latest quarter)
| Measure | PG | Industry percentile |
|---|---|---|
| Cash & short-term investments | $9.9B | 100th |
| Net cash (− = net debt) | −$25.1B | 0th |
| Working capital | −$12.5B | 0th |
| Current ratio | 0.68 | 5th |
| Quick ratio | 0.47 | 11th |
| Cash ratio (cash + ST investments / current liabilities) | 0.26 | 47th |
| Defensive interval (days) | 244 days | 42nd |
Leverage & solvency (latest quarter)
| Measure | PG | Industry percentile |
|---|---|---|
| Total debt | $35.0B | 100th |
| Debt / equity | 0.64 | 32nd |
| Net debt / equity | 0.46 | 26th |
| Debt / assets | 27.7% | 32nd |
| Debt / capital | 39.2% | 32nd |
| Debt / EBITDA | 1.43 | 6th |
| Net debt / EBITDA | 1.03 | 6th |
| Interest coverage (EBIT / interest) | 24.2x | 94th |
| Cash interest coverage | 23.2x | 89th |
| Debt payback (years of OCF) | 1.7 yrs | 12th |
| Liabilities / assets | 57.1% | 42nd |
| IS credit model rating | AA | |
| Implied credit spread (bps) | 80 | 5th |
Efficiency
| Measure | PG | Industry percentile |
|---|---|---|
| Asset turnover | 0.69 | 26th |
| Fixed asset turnover | 3.43 | 17th |
| Inventory turnover | 5.5 | 68th |
| Receivables turnover | 14.2 | 79th |
| Days sales outstanding | 26 days | 21st |
| Days inventory outstanding | 66 days | 32nd |
| Days payables outstanding | 133 days | 84th |
| Cash conversion cycle (days) | −41 days | 5th |
| Capex / revenue | 5.1% | 100th |
| Capex / depreciation | 1.40 | 100th |
| Operating expense ratio | 29.9% | 28th |
Cash flow & earnings quality
| Measure | PG | Industry percentile |
|---|---|---|
| Operating cash flow / net income | 1.27 | 18th |
| FCF / net income | 0.99 | 27th |
| FCF / operating cash flow | 78.3% | 56th |
| Capex / operating cash flow | 21.7% | 44th |
| Accruals ratio | -3.4% | 79th |
| Sloan accruals ratio | -4.0% | 42nd |
| Earnings quality score (0-1) | 1.00 | 73rd |
Scores & forensic checks
| Measure | PG | Industry percentile |
|---|---|---|
| IS score | 64 | 89th |
| IS profitability | 70 | 95th |
| IS growth | 44 | 37th |
| IS value | 48 | 53rd |
| IS momentum | 72 | 63rd |
| IS risk (safety) | 100 | 84th |
| IS quality | 79 | 89th |
| IS balance sheet | 63 | 89th |
| IS earnings quality | 86 | 100th |
| IS cash flow | 67 | 63rd |
| Piotroski F-score (0-9) | 6 | 53rd |
| Altman Z-score | 5.6 | 89th |
| Beneish M-score | −2.67 | 79th |
| Ohlson O-score | −8.85 | 11th |
| IS credit score | 86 | 95th |
Size (TTM)
| Measure | PG | Industry percentile |
|---|---|---|
| Market cap | $370.0B | 100th |
| Revenue | $87.0B | 100th |
| EBITDA | $24.4B | 100th |
| Net income | $16.0B | 100th |
| Free cash flow | $15.9B | 100th |
| Total assets | $126.5B | 100th |
| Shareholders' equity | $54.3B | 100th |
| Employees | 104,000 | 100th |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-13 | Subramaniam Rajesh Director |
Award / grant | 1,438 | — | — | 7,768 |
| 2026-10-13 | Portman Robert Jones Director |
Award / grant | 1,438 | — | — | 6,685 |
| 2026-10-13 | Mcevoy Ashley Director |
Award / grant | 1,438 | — | — | 7,666 |
| 2026-10-13 | Mccarthy Christine M Director |
Award / grant | 1,438 | — | — | 19,342 |
| 2026-10-13 | Kempczinski Christopher J Director |
Award / grant | 1,438 | — | — | 13,372 |
| 2026-10-13 | Jimenez Joseph Director |
Award / grant | 1,438 | — | — | 38,968 |
| 2026-10-13 | Chang Amy Director |
Award / grant | 1,438 | — | — | 18,897 |
| 2026-10-13 | Bonini Sheila Director |
Award / grant | 1,438 | — | — | 5,983 |
| 2026-10-13 | Biggs M. Brett Director |
Award / grant | 1,438 | — | — | 6,900 |
| 2026-10-13 | Arnold Craig Director |
Award / grant | 1,438 | — | — | 4,474 |
| 2026-10-13 | Allen Bertrand Marc Director |
Award / grant | 1,438 | — | — | 12,698 |
| 2026-10-05 | Gama Paul CEO- Health Care |
Open-market sale | 2,225 | $145.34 | $323,382 | 51,124 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Award / grant | Acquired | 106 | 847,882 | $97.9M |
| Open-market sale | Disposed | 18 | 55,019 | $7.9M |
| — | Disposed | 20 | 322,030 | $50.9M |
Form 144 notices
12 months: 29 notices · 483,071 shares · $73.4M| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| 2026-10-01 | Gama Paul | 2,646 | $391,185 |
| 2026-10-01 | Whaley Susan Street | 2,817 | $416,465 |
| 2026-10-01 | Schulten Andre | 4,655 | $688,195 |
| 2026-10-01 | Moeller Jon R | 8,087 | $1.2M |
Congress trades
12 months: House 65 trades (33 purchases) · Senate 4 (0 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-10-12 | David Taylor | House | Sale | $1,001 - $15,000 | 2026-10-16 |
| 2026-09-25 | Ro Khanna | House | Purchase | $1,001 - $15,000 | 2026-10-09 |
| 2026-09-11 | Ro Khanna | House | Purchase | $1,001 - $15,000 | 2026-10-09 |
| 2026-09-08 | David Taylor | House | Purchase | $1,001 - $15,000 | 2026-09-18 |
| 2026-06-08 | Tommy Tuberville | Senate | Sale | $15,001 - $50,000 | 2026-07-16 |
| 2026-06-08 | Thomas Hawley Tuberville | Senate | Sale | $15,001 - $50,000 | 2026-07-16 |
| 2026-03-27 | Alan Armstrong | Senate | Sale | $15,001 - $50,000 | 2026-07-21 |
| 2026-02-26 | John Boozman | Senate | Sale | $1,001 - $15,000 | 2026-03-06 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| BlackRock, Inc. | 190,003,442 | $27.9B | 8.18% |
| VANGUARD CAPITAL MANAGEMENT LLC | 152,109,741 | $22.3B | 6.55% |
| STATE STREET CORP | 102,216,308 | $15.0B | 4.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 66,458,472 | $9.7B | 2.86% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 63,393,374 | $9.3B | 2.73% |
| NORGES BANK | 31,831,692 | $4.7B | 1.37% |
| FMR LLC | 29,298,374 | $4.3B | 1.26% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 28,906,005 | $4.2B | 1.24% |
| FRANKLIN RESOURCES INC | 26,818,630 | $3.9B | 1.15% |
| BANK OF AMERICA CORP /DE/ | 26,259,055 | $3.9B | 1.13% |
| JPMORGAN CHASE & CO | 20,367,360 | $3.0B | 0.88% |
| NORTHERN TRUST CORP | 20,063,651 | $2.9B | 0.86% |
| GOLDMAN SACHS GROUP INC | 16,773,067 | $2.5B | 0.72% |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 15,800,799 | $2.3B | 0.68% |
| Capital World Investors | 15,416,034 | $2.3B | 0.66% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 4,046 | 69.2% | 195 | 1,675 | 1,726 | 123 |
| 2026-03-31 | 4,026 | 66.1% | 229 | 1,712 | 1,673 | 188 |
| 2025-12-31 | 4,052 | 66.0% | 419 | 1,415 | 1,849 | 183 |
| 2025-09-30 | 3,906 | 64.7% | 174 | 1,517 | 1,791 | 166 |
| 2025-06-30 | 3,971 | 66.3% | 169 | 1,595 | 1,767 | 165 |
| 2025-03-31 | 4,031 | 66.5% | 207 | 1,701 | 1,684 | 121 |
| 2024-12-31 | 4,015 | 66.0% | 478 | 1,590 | 1,521 | 121 |
| 2024-09-30 | 3,732 | 65.7% | 196 | 1,571 | 1,523 | 85 |
| 2024-06-30 | 3,667 | 65.6% | 176 | 1,507 | 1,558 | 119 |
| 2024-03-31 | 3,662 | 65.0% | 232 | 1,402 | 1,645 | 113 |
| 2023-12-31 | 3,593 | 64.0% | 344 | 1,363 | 1,513 | 112 |
| 2023-09-30 | 3,415 | 63.4% | 150 | 1,422 | 1,438 | 111 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.5% | 174,810,071 |
| 2025-09-08 | SCHEDULE 13G/A | The Vanguard Group | 10.0% | 235,208,844 |
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.46% | $10.7B |
| VTSAX | 0.46% | $10.7B |
| VTI | 0.46% | $10.7B |
| VSMPX | 0.46% | $10.7B |
| VOO | 0.51% | $8.9B |
| VFIAX | 0.51% | $8.9B |
Share structure
Income statement
Fiscal years, USD| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Revenue | $80.2B | $82.0B | $84.0B | $84.3B | $87.0B |
| Cost of revenue | $42.2B | $42.8B | $40.8B | $41.2B | $43.4B |
| Gross profit | $38.0B | $39.2B | $43.2B | $43.1B | $43.7B |
| R&D | $0 | $0 | $0 | $0 | $0 |
| SG&A | $20.2B | $21.1B | $23.3B | $22.7B | $23.9B |
| Operating income | $17.8B | $18.1B | $18.5B | $20.5B | $19.7B |
| EBITDA | $21.2B | $21.8B | $22.6B | $23.9B | $24.4B |
| Pretax income | $18.0B | $18.4B | $18.8B | $20.2B | $20.4B |
| Income tax | $3.2B | $3.6B | $3.8B | $4.1B | $4.2B |
| Net income | $14.7B | $14.7B | $14.9B | $16.0B | $16.0B |
| EPS, diluted | $5.81 | $5.90 | $6.02 | $6.51 | $6.62 |
| Diluted shares | 2.5B | 2.5B | 2.5B | 2.5B | 2.4B |
Balance sheet
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $7.2B | $8.2B | $9.5B | $9.6B | $9.9B |
| Receivables | $5.1B | $5.5B | $6.1B | $6.2B | $6.1B |
| Inventory | $6.9B | $7.1B | $7.0B | $7.6B | $8.2B |
| Total current assets | $21.7B | $22.6B | $24.7B | $25.4B | $26.2B |
| PP&E, net | $21.2B | $21.9B | $22.2B | $23.9B | $25.4B |
| Goodwill & intangibles | $63.4B | $64.4B | $62.4B | $63.6B | $62.7B |
| Total assets | $117.2B | $120.8B | $122.4B | $125.2B | $126.5B |
| Accounts payable | $14.9B | $14.6B | $15.4B | $15.2B | $16.3B |
| Total current liabilities | $33.1B | $35.8B | $33.6B | $36.1B | $38.7B |
| Long-term debt | $22.8B | $24.4B | $25.3B | $25.0B | $22.8B |
| Total liabilities | $70.4B | $73.8B | $71.8B | $72.9B | $72.2B |
| Shareholders' equity | $46.9B | $47.1B | $50.6B | $52.3B | $54.3B |
Cash flow statement
Outflows are negative| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Net income | $14.8B | $14.7B | $14.9B | $16.1B | $16.1B |
| Depreciation & amortization | $2.8B | $2.7B | $2.9B | $2.8B | $3.2B |
| Stock-based compensation | $528.0M | $545.0M | $562.0M | $476.0M | $524.0M |
| Change in working capital | −$1.1B | −$1.2B | −$436.0M | −$2.5B | $362.0M |
| Operating cash flow | $16.7B | $16.8B | $19.8B | $17.8B | $19.6B |
| Capital expenditure | −$3.2B | −$3.1B | −$3.3B | −$3.8B | −$4.4B |
| Free cash flow | $13.6B | $13.8B | $16.5B | $14.0B | $15.1B |
| Investing cash flow | −$4.4B | −$3.5B | −$3.5B | −$3.8B | −$4.6B |
| Net debt issued / repaid | $1.9B | $2.9B | −$2.4B | $630.0M | −$107.0M |
| Buybacks | −$10.0B | −$7.4B | −$5.0B | −$6.5B | −$5.0B |
| Dividends paid | −$8.8B | −$9.0B | −$9.3B | −$9.9B | −$10.2B |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Gross margin | 47.4% | 47.9% | 51.4% | 51.2% | 50.2% |
| Operating margin | 22.2% | 22.1% | 22.1% | 24.3% | 22.7% |
| Net margin | 18.4% | 17.9% | 17.7% | 19.0% | 18.4% |
| FCF margin | 16.9% | 16.8% | 21.1% | 16.7% | 18.3% |
| ROE | 31.7% | 31.4% | 30.7% | 31.2% | 30.2% |
| ROIC | 20.4% | 19.7% | 20.0% | 20.9% | 19.7% |
| ROA | 12.5% | 12.3% | 12.2% | 12.9% | 12.7% |
| Debt / equity | 0.69 | 0.76 | 0.66 | 0.68 | 0.64 |
| Interest coverage | 42.0x | 25.3x | 21.3x | 23.2x | 24.2x |
| Current ratio | 0.65 | 0.63 | 0.73 | 0.70 | 0.68 |
| Revenue growth | +5.3% | +2.3% | +2.5% | +0.3% | +3.3% |
| EPS growth | +5.1% | +1.2% | +1.8% | +8.1% | +1.8% |
| P/E at year end | 22.5x | 24.1x | 26.4x | 24.1x | 22.1x |
| EV / EBITDA at year end | 16.8x | 17.4x | 18.4x | 17.2x | 15.6x |
| FCF yield at year end | 4.09% | 3.91% | 4.53% | 3.64% | 4.48% |
| Dividend payout | 59.5% | 61.4% | 62.6% | 61.8% | 63.8% |
Revenue by segment
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Fabric Care And Home Care Segment Member | $27.6B | $28.4B | $29.5B | $29.6B | $30.3B |
| Baby, Feminine and Family Care Segment Member | $19.7B | $20.2B | $20.3B | $20.2B | $20.4B |
| Beauty Segment | $14.7B | $15.0B | $15.2B | $15.0B | $16.0B |
| Health Care Segment Member | $10.8B | $11.2B | $11.8B | $12.0B | $12.5B |
| Grooming Segment Member | $6.6B | $6.4B | $6.7B | $6.7B | $6.9B |
| Corporate Segment | $744.0M | $765.0M | $601.0M | — | — |
Revenue by region · FY2026
Street estimates by fiscal year
Next report 2026-10-22 · consensus EPS $1.88 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $87.1B | $86.6B – $88.1B | $6.88 | $6.84 – $6.90 | 14 | 23.2x |
| 2027 | $88.8B | $88.1B – $89.3B | $6.97 | $6.90 – $7.03 | 15 | 22.8x |
| 2028 | $91.3B | $90.0B – $92.5B | $7.39 | $7.22 – $7.47 | 15 | 21.6x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-04-24 | $1.56 | $1.59 | +1.9% | $20.5B | $21.2B | +3.4% |
| 2026-01-22 | $1.86 | $1.88 | +1.1% | $22.3B | $22.2B | −0.4% |
| 2025-10-24 | $1.90 | $1.99 | +4.7% | $22.2B | $22.4B | +0.9% |
| 2025-07-29 | $1.42 | $1.48 | +4.2% | $20.8B | $20.9B | +0.2% |
| 2025-04-24 | $1.52 | $1.54 | +1.3% | $20.2B | $19.8B | −1.9% |
| 2025-01-22 | $1.89 | $1.88 | −0.5% | $21.6B | $21.9B | +1.4% |
| 2024-10-18 | $1.90 | $1.93 | +1.6% | $22.0B | $21.7B | −1.1% |
| 2024-07-30 | $1.37 | $1.40 | +2.2% | $20.7B | $20.5B | −0.9% |
| 2024-04-19 | $1.41 | $1.52 | +7.8% | $20.4B | $20.2B | −1.2% |
| 2024-01-23 | $1.70 | $1.84 | +8.2% | $21.5B | $21.4B | −0.2% |
| 2023-10-18 | $1.72 | $1.83 | +6.4% | $20.4B | $21.9B | +7.0% |
| 2023-07-28 | $1.32 | $1.37 | +3.8% | $18.0B | $20.6B | +13.9% |
| 2023-04-21 | $1.32 | $1.37 | +3.8% | $20.0B | $20.1B | +0.4% |
| 2023-01-19 | $1.59 | $1.59 | 0.0% | $20.7B | $20.8B | +0.1% |
| 2022-10-19 | $1.54 | $1.57 | +1.9% | $20.4B | $20.6B | +1.2% |
| 2022-07-29 | $1.22 | $1.21 | −0.8% | $19.4B | $19.5B | +0.6% |
| 2022-04-20 | $1.29 | $1.33 | +3.1% | $18.7B | $19.4B | +3.6% |
| 2022-01-19 | $1.65 | $1.66 | +0.6% | $18.8B | $21.0B | +11.6% |
| 2021-10-19 | $1.59 | $1.61 | +1.3% | $19.7B | $20.3B | +3.0% |
| 2021-07-30 | $1.08 | $1.13 | +4.6% | $18.9B | $18.9B | 0.0% |
| 2021-04-20 | $1.19 | $1.26 | +5.9% | $17.0B | $18.1B | +6.3% |
| 2021-01-20 | $1.51 | $1.64 | +8.6% | $18.0B | $19.7B | +9.4% |
| 2020-10-20 | $1.42 | $1.63 | +14.8% | $16.8B | $19.3B | +14.8% |
| 2020-07-30 | $1.01 | $1.16 | +14.9% | $15.4B | $17.7B | +14.9% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $1.2B | 8,005,656 | 145,018 |
| 2026-08-24 | $901.1M | 6,224,718 | 125,402 |
| 2026-08-17 | $1.8B | 12,323,595 | 173,103 |
| 2026-08-10 | $1.1B | 7,322,947 | 134,049 |
| 2026-08-03 | $1.3B | 9,149,849 | 154,331 |
| 2026-07-27 | $1.9B | 13,051,525 | 196,910 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 32.9% | 1,677,157 | 5,092,772 |
| 2026-10-14 | 30.6% | 1,146,147 | 3,745,545 |
| 2026-10-13 | 27.2% | 581,963 | 2,137,470 |
| 2026-10-12 | 32.0% | 668,369 | 2,085,605 |
| 2026-10-09 | 30.2% | 722,654 | 2,391,957 |
| 2026-10-08 | 49.8% | 1,122,466 | 2,251,758 |
| 2026-10-07 | 44.0% | 866,058 | 1,966,760 |
| 2026-10-06 | 44.6% | 1,138,973 | 2,554,739 |
| 2026-10-05 | 37.9% | 664,669 | 1,754,201 |
| 2026-10-02 | 35.6% | 634,169 | 1,780,574 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| Jan | −0.6% | 50% | 20 |
| Feb | −0.5% | 55% | 20 |
| Mar | +0.4% | 52% | 21 |
| Apr | +0.5% | 50% | 20 |
| May | −0.8% | 40% | 20 |
| Jun | −0.3% | 40% | 20 |
| Jul | +2.3% | 70% | 20 |
| Aug | +1.6% | 70% | 20 |
| Sep | +0.2% | 55% | 20 |
| Oct | +1.7% | 65% | 20 |
| Nov | +2.2% | 70% | 20 |
| Dec | +0.7% | 55% | 20 |
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About The Procter & Gamble Company
The Procter & Gamble Company, commonly referred to as P&G, is a global enterprise that supplies a broad spectrum of branded consumer products to markets worldwide. The company's operations are divided into five main business divisions: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers an assortment of hair care products, including conditioners, shampoos, styling aids, and treatments, under popular names like Head & Shoulders, Herbal Essences, Pantene, and Rejoice. It also features antiperspirants, deodorants, personal cleansing solutions, and skin care items from brands such as Olay, Old Spice, Safeguard, Secret, and SK-II. Within the Grooming division, P&G provides a range of shave care products and grooming appliances, prominently featuring brands like Braun, Gillette, and Venus. The Health Care unit encompasses oral hygiene essentials, including toothbrushes, toothpastes, and other dental care products sold under the Crest and Oral-B brand names. This segment further extends to gastrointestinal remedies, rapid diagnostics, respiratory care, vitamins/minerals/supplements, pain relief, and various other personal health care items from brands such as Metamucil, Neurobion, Pepto-Bismol, and Vicks. In the Fabric & Home Care category, consumers find fabric enhancers, laundry additives, and laundry detergents through labels like Ariel, Downy, Gain, and Tide. Additionally, this division offers air care products, dishwashing solutions, professional cleaning supplies (P&G Professional), and surface cleaners, exemplified by brands such as Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer. Finally, the Baby, Feminine & Family Care segment provides infant care products, including baby wipes, taped diapers, and pants, under the Luvs and Pampers brands. It also supplies adult incontinence and feminine hygiene products from Always, Always Discreet, and Tampax, along with paper towels, tissues, and toilet paper marketed as Bounty, Charmin, and Puffs. P&G distributes its extensive product portfolio through a vast commercial network, including large retail chains, e-commerce platforms, grocery stores, membership clubs, pharmacies, department stores, various distributors, wholesalers, specialty beauty retailers, high-frequency stores, electronics outlets, and professional channels, as well as direct-to-consumer sales. The Procter & Gamble Company was established in 1837 and its corporate headquarters are located in Cincinnati, Ohio.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Jon R. Moeller | Executive Officer | $3.8M | 1964 |
| Shailesh G. Jejurikar | CEO, President & Chairman | $3.4M | 1967 |
| Balaji Purushothaman | Chief Human Resources Officer | $3.4M | 1969 |
| Sundar G. Raman | CEO of Fabric & Home Care, and Executive Sponsor for Corporate Sustainability | $2.2M | 1975 |
| Andre Schulten | Chief Financial Officer | $2.0M | 1971 |
| Marc S. Pritchard | Chief Brand Officer | $1.8M | 1960 |
| John T. Chevalier | Senior Vice President of Investor Relations | — | — |
| Melinda Sherwood | President of North America & Chief Sales Officer | — | 1967 |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Jon R. Moeller Chairman of the Board, President, and CEO | 2025 | $1.6M | $11.5M | $0 | $21.9M |
| Shailesh Jejurikar Chief Operating Officer | 2025 | $1.2M | $3.6M | $0 | $9.6M |
| Andre Schulten Chief Financial Officer | 2025 | $1.0M | $3.4M | $0 | $8.5M |
| Sundar Raman CEO - Fabric and Home Care | 2025 | $912,500 | $2.3M | $0 | $7.2M |
| Jennifer L. Davis CEO - Health Care | 2025 | $895,000 | $2.2M | $0 | $6.0M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-10-23 | $1.089 | 2026-11-16 |
| 2026-07-24 | $1.089 | 2026-08-17 |
| 2026-04-24 | $1.089 | 2026-05-15 |
| 2026-01-23 | $1.057 | 2026-02-17 |
| 2025-10-24 | $1.057 | 2025-11-17 |
| 2025-07-18 | $1.057 | 2025-08-15 |
| 2025-04-21 | $1.057 | 2025-05-15 |
| 2025-01-24 | $1.006 | 2025-02-18 |